Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4144141 | 0.88 | ALDH1A1 (0.33) | TSHRALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL15380000 | 0.84 | FAAH (0.37) | TSHRALDH1A1ACHE | |
| SCHEMBL786190 | 0.79 | ACHE (0.39) | TSHRALDH1A1ACHECHRNB2CHRNB4 | |
| SCHEMBL13876695 | 0.79 | ACHE (0.39) | TSHRALDH1A1ACHECHRNB2CHRNB4 | |
| SCHEMBL15521662 | 0.79 | ACHE (0.39) | TSHRALDH1A1ACHECHRNB2CHRNB4 | |
| SCHEMBL12893358 | 0.79 | TSHR (0.38) | TSHRALDH1A1ACHECHRNB2CHRNB4 | |
| SCHEMBL20515383 | 0.78 | TSHR (0.34) | TSHRALDH1A1ACHE | |
| SCHEMBL21733115 | 0.77 | TSHR (0.37) | TSHRALDH1A1ACHECHRNB2CHRNB4 | |
| SCHEMBL17365966 | 0.77 | TSHR (0.37) | TSHRALDH1A1ACHECHRNB2CHRNB4 | |
| SCHEMBL20448324 | 0.77 | TSHR (0.37) | TSHRALDH1A1ACHECHRNB2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115161011-B | High-stability perovskite phase CsPbI 3 Nanocrystalline and preparation method thereof | 上海电力大学 | 2024-03-01 | — | — | CN | claimed |
| CN-115161011-A | High-stability perovskite phase CsPbI 3 Nanocrystalline and preparation method thereof | 上海电力大学 | 2022-10-11 | — | — | CN | claimed |
| CN-115161011-B | High-stability perovskite phase CsPbI 3 Nanocrystalline and preparation method thereof | 上海电力大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-115161011-A | High-stability perovskite phase CsPbI 3 Nanocrystalline and preparation method thereof | 上海电力大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-114773202-A | Preparation method and application of probe for analyzing influence of interpenetrating network topology structure on material performance | 电子科技大学长三角研究院(湖州) | 2022-07-22 | — | — | CN | disclosed |
| US-20210208140-A1 | DIAGNOSTIC METHODS FOR THE DETECTION AND QUANTIFICATION OF BLOOD-RELATED DISEASES | ADOLPHE MERKLE INSTITUTE, UNIVERSITY OF FRIBOURG (CH) | 2021-07-08 | — | — | US | disclosed |
| EP-3458859-B1 | DIAGNOSTIC METHODS FOR THE DETECTION AND QUANTIFICATION OF BLOOD-RELATED DISEASES | ADOLPHE MERKLE INSTITUTE UNIV OF FRIBOURG (CH) | 2021-07-07 | — | — | EP | disclosed |
| CN-107573445-B | Polymer backbone element tag | 富鲁达加拿大公司 | 2021-05-25 | — | — | CN | disclosed |
| US-10983122-B2 | Diagnostic methods for the detection and quantification of blood-related diseases | ADOLPHE MERKLE INSTITUTE, UNIVERSITY OF FRIBOURG (CH) | 2021-04-20 | — | — | US | disclosed |
| CN-107076741-B | Polymer microparticles for loading physiologically active substance and process for producing the same | 美迪恩斯生命科技株式会社 | 2020-11-24 | — | — | CN | disclosed |
| US-20190160007-A1 | Integrated Nano System for Liver-Targeting Co-Delivery of Genes/Drugs and Preparation Method | JIANGNAN UNIVERSITY (CN) | 2019-05-30 | — | — | US | disclosed |
| US-20090198327-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON INC. (CH) | 2009-08-06 | — | — | US | disclosed |
| US-20090093604-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON, INC. (CH) | 2009-04-09 | — | — | US | disclosed |
| WO-2009046235-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON, INC. (CH) | 2009-04-09 | — | — | WO | disclosed |
| EP-1891127-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON INC. (CH) | 2008-02-27 | — | — | EP | disclosed |
| EP-1891466-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON INC. (CH) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006138188-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON, INC. (CH) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006138213-A1 | OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS | ALCON, INC. (CH) | 2006-12-28 | — | — | WO | disclosed |
| US-20060282163-A1 | Ophthalmic and otorhinolaryngological device materials | ALCON, INC. | 2006-12-14 | — | — | US | disclosed |
| US-20060281888-A1 | Ophthalmic and otorhinolaryngological device materials | ALCON, INC. | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190160007-A1 | Integrated Nano System for Liver-Targeting Co-Delivery of Genes/Drugs and Preparation Method | GUSB, GDA, GLA | TSHR 2848/4885ALDH1A1 573/4885ACHE 2513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.